ACTRN12622000798763已完成未知
An examination of the short-term anxiolytic effects of an Echinacea extract (Anxiofit-1/EP107) in adults experiencing increased anxiety: A randomised, double-blind, placebo-controlled trial
Clinical Research Australia0 个研究点目标入组 82 人开始时间: 2022年6月7日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 82
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 80 Years（—）
- 性别
- All
入选标准
- •1.Generally, healthy adults (male and female) aged 18 to 80 years
- •2.Currently self-reporting experiencing high stress and/or anxiety
- •3.A score of 45 or higher on the STAI-state subscale
- •4.Non-smoker
- •5.BMI between 18 and 30 kg/m2
- •6.No plan to commence new treatments over the study period
- •7.Understand, willing and able to comply with all study procedures
- •8.Willing to provide a personally signed and dated informed consent form detailing all pertinent aspects of the trial.
排除标准
- •1.Currently receiving, or in the previous 3 months, psychological intervention for anxiety or depression.
- •2.Diagnosis of psychiatric or neurological conditions including but not limited to: any psychiatric disorder, or neurological disease (Parkinson’s, Alzheimer’s disease, intracranial haemorrhage, head or brain injury)
- •3.Suffering from recently diagnosed or unmanaged medical conditions including but not limited to: diabetes, hyper/hypotension, cardiovascular disease, gastrointestinal disease requiring regular use of medications, gallbladder disease, autoimmune disease, endocrine disease, acute or chronic pain condition, or cancer/malignancy
- •4.Regular medication intake including but not limited to anticholinergics, anti-epileptics, antihistamines, benzodiazepines, opioids, or corticosteroids.
- •5.Change in medication in the last 3 months or expectation to change during the study duration
- •6.In the last 6 months, commenced or changed dose of nutritional and/or herbal supplements that may impact on treatment outcome
- •7.Current or 12-month history of illicit drug abuse
- •8.Alcohol intake greater than 14 standard drinks per week
- •9.Participation in any other clinical trial in the last 3 months
- •10.Any significant surgeries over the last year
- •11.Overnight shift workers
- •12.Pregnant, breast-feeding or women who plan to fall pregnant 3 months after the end of the study.
- •13.Planned major lifestyle change in the next 2 months
- •14.Known allergy to Echinacea, chamomile or sunflower oil.
研究者
相似试验
招募中
Unknown
A further examination of the short-term anxiolytic effects of an Echinacea extract (EP107)in adults experiencing increased anxietyAnxietyACTRN12623001231639Clinical Research Australia80
尚未招募
2 期
To compare the anxiety reducing effect of two oral medicines for uncooperative children during dental proceduresCTRI/2023/11/059366Dr Anshula Deshpande
已完成
不适用
The effectiveness of anxiety regulation short term dynamic psychotherapy (STDP) on improve coping styles and decrease depression symptoms for mothers of children diagnosed primary immunodeficiency diseasesMood [affective] disorders.Moderate depressive episodeIRCT2015030212237N3Charity of mother's kindness Raha16
已完成
不适用
The effectiveness of anxiety regulation short term dynamic psychotherapy (STDP) on anticipatory grief and psychological wellbeing for mothers of children diagnosed primary immunodeficiency diseasesMood [affective] disorders.Mild depressive episodeIRCT2014091612237N2Charity of Raha mother's kindness16
已完成
不适用
The effectiveness of anxiety-regulation short-term dynamic psychotherapy(STDP) on defense styles and emotional expressiveness in social phobia patientssocial phobia.social phobiasIRCT2013012212237N1Ferdowsi University of Mashhad6